Variation in immunoglobulin use and impact on survival in myeloma

Abstract Serious infection is common in patients with multiple myeloma due to immune deficiency from the underlying disease and/or its treatment. Immunoglobulin replacement is one approach to reduce infection risk in these patients. However, few real‐world data exist on its use in patients with myel...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Khai Li Chai, Cameron Wellard, LTP Thao, Naomi Aoki, Elizabeth M Moore, Bradley M Augustson, Akshay Bapat, Hilary Blacklock, Wee J Chng, Rachel Cooke, Cecily J Forsyth, Yeow‐Tee Goh, Nada Hamad, Simon J Harrison, P Joy Ho, Jay Hocking, Ian Kerridge, Jin Seok Kim, Kihyun Kim, Tracy King, Georgia J McCaughan, Peter Mollee, C Orla Morrissey, Nick Murphy, Hang Quach, Xuan Ni Tan, Allison CY Tso, Kimberly SQ Wong, Sung‐Soo Yoon, Andrew Spencer, Erica M Wood, Zoe K McQuilten
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2024-08-01
Serija:	eJHaem
Teme:	immunoglobulin infection multiple myeloma
Online dostop:	https://doi.org/10.1002/jha2.938
Oznake:	Označite Brez oznak, prvi označite!